Your browser doesn't support javascript.
Re-thinking patient stability for methadone in opioid treatment programs during a global pandemic: Provider perspectives.
Hatch-Maillette, Mary A; Peavy, K Michelle; Tsui, Judith I; Banta-Green, Caleb J; Woolworth, Stephen; Grekin, Paul.
  • Hatch-Maillette MA; Alcohol and Drug Abuse Institute, University of Washington, Seattle, WA 98105, United States of America; Department of Psychiatry & Behavioral Sciences, University of Washington School of Medicine, Seattle, WA 98195, United States of America. Electronic address: hatchm@uw.edu.
  • Peavy KM; Evergreen Treatment Services, 1700 Airport Way S., Seattle, WA 98134, United States of America.
  • Tsui JI; Evergreen Treatment Services, 1700 Airport Way S., Seattle, WA 98134, United States of America; Division of Internal Medicine, University of Washington School of Medicine, Seattle, WA 98195, United States of America.
  • Banta-Green CJ; Alcohol and Drug Abuse Institute, University of Washington, Seattle, WA 98105, United States of America; Department of Health Services, University of Washington School of Public Health, Seattle, WA 98195, United States of America.
  • Woolworth S; Evergreen Treatment Services, 1700 Airport Way S., Seattle, WA 98134, United States of America.
  • Grekin P; Department of Psychiatry & Behavioral Sciences, University of Washington School of Medicine, Seattle, WA 98195, United States of America; Evergreen Treatment Services, 1700 Airport Way S., Seattle, WA 98134, United States of America.
J Subst Abuse Treat ; 124: 108223, 2021 05.
Article in English | MEDLINE | ID: covidwho-957257
ABSTRACT
COVID-19 necessitated rapid changes in methadone take-home policies in opioid treatment programs (OTPs); these changes markedly contrast with existing, long-standing federal mandates on OTP rules about take-home methadone. OTP providers describe how these changes have affected clinical decision-making, equity in patient care, and workflow. We also discuss implications for medical ethics and patient autonomy. We provide suggestions for future research that will examine the impact of COVID-19 on OTP treatment and its patients, as well as the effect of making methadone take-home polices patient centered, all of which may foreshadow larger changes in the ways OTPs deliver their services.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Health Personnel / Clinical Decision-Making / COVID-19 / Methadone / Opioid-Related Disorders Type of study: Prognostic study Limits: Humans Language: English Journal: J Subst Abuse Treat Journal subject: Substance-Related Disorders Year: 2021 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Health Personnel / Clinical Decision-Making / COVID-19 / Methadone / Opioid-Related Disorders Type of study: Prognostic study Limits: Humans Language: English Journal: J Subst Abuse Treat Journal subject: Substance-Related Disorders Year: 2021 Document Type: Article